Centuria (ASX:CNI) share price down after $162 million in equity raising in 8 weeks

The Centuria share price is edging lower today, despite the company reporting $162 million of equity raising in 2021 across 3 funds.

| More on:
white arrow pointing down

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Centuria Capital Group (ASX: CNI) share price is edging lower today, down 1% in afternoon trading. At the time of writing, the Centuria share price was trading at $2.32.

Shares have been lagging the returns from the S&P/ASX 200 Index (ASX: XJO) despite the specialist investment manager recently upgrading its earnings guidance to 10.0 cents per share (cps).

According to Centuria, the earnings guidance upgrade was supported by the company's $162 million in equity raising since 3 January. This was for 3 unlisted real estate funds. The 2021 equity raises to date support a total of more than $286 million of industrial and healthcare property.

These funds are not listed on the ASX, with the investment funds managed directly by Centuria.

What did Centuria report on its real estate fund equity raisings?

Centuria reported that Augusta Capital, its New Zealand platform, raised NZ$109 million (AU$102.5 million). This is for its Augusta Penrose Limited fund. The capital raising was used to settle Centuria's acquisition of the Visy Glass manufacturing facility. Centuria forecasts an initial pre-tax annual cash distribution of 5% from the fund.

So far in 2021 Centuria also raised $40 million for its newly launched Centuria Industrial Income Fund No.1 (CIIF1). That fund encompasses 3 industrial assets in Adelaide and Brisbane.

The third fund to see a major equity inflow since 2 January was the Centuria Healthcare Property Fund (CHPF). The company reported CHPF has raised $20 million in the advance bookbuild. This is prior to the fund opening for applications later this month for the third time.

Jason Huljich, Centuria's Joint CEO commented:

It's exciting to confirm the significant funds we have raised in the eight short weeks of the 2021 calendar year across Australia and New Zealand. These unlisted single asset and multi-asset funds comprise hotly contested assets across the industrial and healthcare sectors.

So what about the office markets?

According to Huljich, there is light at the end of the tunnel for the embattled office sector. He says, "[W]e are still confident and optimistic about the decentralised office markets. With the rollout of the COVID-19 vaccine now underway, we anticipate white-collar workers across Australia will continue to return to the office."

Centuria share price snapshot

Having yet to fully recover from the pandemic driven market selloff last February and March, Centuria's share remains down 9% over the past year. By comparison, the ASX 200 is up 6% in that same time.

So far in 2021, the Centuria share price is down 10%.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Share Market News

Macquarie says this top ASX tech stock could rise 15%

Let's see what the broker is saying about this stock.

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Collins Foods, Monash IVF, Premier Investments, and Step One shares are tumbling today

These shares are ending the week in the red. But why?

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Share Gainers

4 ASX 200 stocks smashing the benchmark this week

Investors have been piling into these four ASX 200 stocks this week. Let’s see why.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Bendigo Bank, NextDC, Nuix, and Vulcan Energy shares are rising today

These shares are ending the week on a high. But why?

Read more »

Time to sell ASX 200 shares written on a clock.
Share Market News

Sell alert! Why analysts are calling time on these 2 ASX 300 stocks

Two leading investment experts recommend selling these ASX 300 shares today. But why?

Read more »